# SpyGlass Pharma funding: rounds and investors

> SpyGlass Pharma has raised $165M across 2 rounds since 2023. Investors include New Enterprise Associates, RA Capital Management and Samsara BioCapital.

Source: https://millionrounds.com/company/spyglass-pharma (Millionrounds; every figure on the page links to its filing or article)

United States · [Series D startup](https://millionrounds.com/companies)

# Who invested in *SpyGlass Pharma*

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Delivery Healthtech

Funding summary Updated 26 Oct 2026

**$165M** raised across 2 rounds since 2023, from 3 sources

**$90M** Series C **$75M** Series D

- **Latest round:** Series D, $75M Jun 2025
- **Biggest round:** $90M Series C · Jul 2023
- **Investors:** 4

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2024 2025

**$90M** Series C

**$75M** Series D

- **First round:** Series C, $90M
- **Biggest round:** $90M
- **Between rounds:** 23 months

## The rounds

- **Jun 2025** Series D **$75M** *4 new* [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [Samsara BioCapital](https://millionrounds.com/fund/samsara-biocapital) [Sands Capital Ventures](https://millionrounds.com/fund/sands-capital-ventures) Reported by Vensana Capital and 1 other
- **Jul 2023** Series C **$90M** No investor was named in the report. Reported by Vensana Capital

## Founders and team

From SpyGlass Pharma's own website: 11 on the team.

- **Patrick Mooney** Chief Executive Officer
- **Laurie Mellott** Vice President, Clinical Operations
- **Mike Pinder** Vice President, Marketing
- **Nina Nguyen** Senior Vice President, Regulatory & Quality
- **Paul Yoo** Senior Vice President, Clinical Development
- **James Dennewill** Chief Operating Officer
- **Jean-Frédéric Viret** Chief Financial Officer
- **Elizabeth O’Farrell** Board Director
- **Geoff Pardo** Board Director, Gilde Healthcare US
- **Habib J. Dable** Board Director
- **SkyVision Centers** Board Advisors

Advisers *Aziz Mottiwala* *David Van Meter*

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Series C** 2023 **Series D** 2025 [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [Samsara BioCapital](https://millionrounds.com/fund/samsara-biocapital) [Sands Capital Ventures](https://millionrounds.com/fund/sands-capital-ventures)

## Everyone who backed them

[New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) VC firm **1** round

[RA Capital Management](https://millionrounds.com/fund/ra-capital-management) Private equity **1** round

[Samsara BioCapital](https://millionrounds.com/fund/samsara-biocapital) VC firm **1** round

[Sands Capital Ventures](https://millionrounds.com/fund/sands-capital-ventures) Private equity **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=spyglass-pharma).

## Quick answers about SpyGlass Pharma

### Who invested in SpyGlass Pharma?

SpyGlass Pharma's investors include New Enterprise Associates, RA Capital Management, Samsara BioCapital and Sands Capital Ventures.

### How much has SpyGlass Pharma raised?

SpyGlass Pharma has raised $165M across 2 rounds since 2023.

### When did SpyGlass Pharma last raise?

SpyGlass Pharma's most recent round was a Series D of $75M in Jun 2025.

### What was SpyGlass Pharma's biggest round?

SpyGlass Pharma's largest round on record is $90M (Series C), in Jul 2023.

### Who backed SpyGlass Pharma first?

SpyGlass Pharma's first round on record, in Jun 2025, was backed by New Enterprise Associates, RA Capital Management and Samsara BioCapital and 1 others.

### What stage is SpyGlass Pharma at?

SpyGlass Pharma's latest named round is a Series D, in Jun 2025.

### Where is SpyGlass Pharma based?

SpyGlass Pharma is based in the United States.

## Companies like SpyGlass Pharma

In the same sector, and raised in the last eighteen months.

[**Stride** $16M · Oct 2026](https://millionrounds.com/company/stride)[**Allswell** $15M · Oct 2026](https://millionrounds.com/company/allswell)[**Brellium** $40M · Oct 2026](https://millionrounds.com/company/brellium)[**Allara** $56M · Oct 2026](https://millionrounds.com/company/allara)[**Sabi** $50M · Oct 2026](https://millionrounds.com/company/sabi)[**Rx Bandz** Oct 2026](https://millionrounds.com/company/rx-bandz)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app